If you require further searching capabilities for announcements please email: data@nzx.com
24 July 2020 Results of Blis Technologies Limited Annual Shareholder Meeting At Blis Technologies Limited's shareholder meeting, held in Dunedin today, shareholders were asked to vote on 3 resolutions, which were supported by the Board. As required by NZX Listing Rule 6.1, all voting was conducted by a poll. The resolutions passed by shareholders were: o That Mr Antony Balfour be elected as a director of the Company. o That pursuant to NZX Listing Rule 2.11.1, the maximum aggregate amount of remuneration payable by the Company to Directors be increased from $265,000 per annum to $309,000 per annum. o That the Directors be authorised to fix the remuneration of the auditors for the ensuing year. Details of the total number of votes cast in person or by a proxy holder are detailed in the attachment. For and on behalf of the Board Anthony Offen Chairman ENDS About Blis Technologies Ltd Delivering proven health benefits through evidence-based, advanced probiotics Blis is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support and teeth and gum health. BLIS products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz. End CA:00356845 For:BLT Type:MEETING Time:2020-07-24 15:29:15